Newsroom
Keep in touch
Join our mailing list to receive new information relating to biomarker discovery and detection.
Exazym®: New Detection Limits Open New Possibilities
26/09/2024Exazym® — Pixels to Proteins
26/09/2024Exazym® — Ultra-Sensitivity Meets Practicality
26/09/2024Exazym® — A Breakthrough in Precision Health
26/09/2024Now, attomole-level detection of low-abundance biomarkers using standard ELISA workflows
02/04/2024 Continue readingPioneering the Future of Healthcare: Cavidi's BOLD Role in Harnessing the Power of Rare Biomarkers
22/01/2024 Continue readingCavidi launches novel platform technology - Exazym®
17/05/2021To showcase of the potential utility of Exazym®, we have demon...
Continue readingNordic Collaboration for SARS-CoV-2 virology and serology testing
13/07/2020Nordic virus monitoring and diagnostics’ companies Cavidi and ...
Continue readingOlof Larsson joins Cavidi as R&D Director
09/04/2020Olof has an academic background with a Ph.D. Pharmacology and a ...
Continue readingCOVID-19 and HIV how we can learn from pandemics
30/03/2020In times of uncertainty and crisis, clear information saves live...
Continue readingWalter Campos MBA, MSc, PhD Virology has been promoted to Commercial Director, Africa
05/03/2020Walter Campos MBA, MSc, PhD Virology has been promoted to Commer...
Continue reading